Citation

Frohman EM, Greenberg BM, Ratchford J, Zivadinov R. Johns Hopkins Advanced Studies in Medicine 2012; 12(1): 6-16.

Copyright

(Copyright © 2012)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide attempt; risk assessment; risk factor; article; disease association; disease course; nuclear magnetic resonance imaging; placebo; food and drug administration; interferon; sensitivity and specificity; follow up; meta analysis; risk management; disease exacerbation; high risk patient; relapse; side effect; multiple sclerosis; flushing; alpha2a interferon; disease activity; atrioventricular block; glatiramer; outcome assessment; injection site reaction; interferon beta serine; mitoxantrone; natalizumab; progressive multifocal leukoencephalopathy; Expanded Disability Status Scale; heart ejection fraction; fingolimod; retina macula edema; injection site necrosis; phase 3 clinical trial (topic); neurologist